The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice.
Sheba Medical Center, Tel Hashomer, Israel, Tel Aviv University, Tel Aviv, Israel.
Miri
M
Blank
Yair
Y
Levy
Howard
H
Amital
Yehuda
Y
Shoenfeld
Mark
M
Pines
Olga
O
Genina
D000818:Animals; D003094:Collagen / Q000378:metabolism; D005355:Fibrosis; D016756:Immunoglobulins, Intravenous; D007371:Interferon-gamma / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D051379:Mice; D008817:Mice, Mutant Strains; D012595:Scleroderma, Systemic / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012867:Skin / Q000378:metabolism / Q000473:pathology; D013154:Spleen / Q000276:immunology / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism; D053773:Transforming Growth Factor beta1
D016756:Immunoglobulins, Intravenous; C508961:Tgfb1 protein, mouse; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D015847:Interleukin-4; D007371:Interferon-gamma; D003094:Collagen